🇺🇸 FDA
Patent

US 10849878

Agent exhibiting anti-stress, anxiolytic and anti-depression activity, and composition based thereon

granted A61KA61K31/375A61K31/4415

Quick answer

US patent 10849878 (Agent exhibiting anti-stress, anxiolytic and anti-depression activity, and composition based thereon) held by OBSHCHESTVO S OGRANICHENNOY OTVETSTVENNOSTYU “NORMOFARM” expires Mon Nov 26 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
OBSHCHESTVO S OGRANICHENNOY OTVETSTVENNOSTYU “NORMOFARM”
Grant date
Tue Dec 01 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 26 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
5
CPC classes
A61K, A61K31/375, A61K31/4415, A61K31/51, A61K45/06